Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA

Showing 15 posts of 1442 posts found.

FDA image

FDA lifts ban on Pfizer Lilly pain study

March 24, 2015
Research and Development, Sales and Marketing Cancer, FDA, Pfizer, lilly, pain, tanezumab

Pfizer and Eli Lilly will resume Phase III clinical trials of tanezumab following the FDA lifting a ban on trials …

News

Pfizer, Novartis and Celgene among late-stage psoriasis trial advances

March 23, 2015
Sales and Marketing Celgene, Cosentyx, Enbrel, FDA, Novartis, Pfizer, otezla, psoriasis, tofacitinib

Pfizer bosses say they are confident of a positive FDA application for tofacitinib after announcing positive Phase III study results. …

News
Breo image

GSK and Theravance see FDA nod for asthma indication

March 20, 2015
Sales and Marketing Advair, AstraZeneca, Dulera, FDA, Foradil, GSK, Merck, Symbicort, Theravance, asthma, breo, budesonide/formoterol fumarate dihydratem, ellipta, fluticasone propionate, formoterol fumarate, mometasone/formoterol

An FDA panel has recommended the approval of asthma treatment Breo Ellipta in adults – but voted against supporting its …

News
Obama image

Pharma to profit from Obama reforms

March 18, 2015
Sales and Marketing FDA, GlobalData, Obama, US, healthcare, insurance

President Obama’s healthcare reforms will drive massive growth in the US pharma market a new report is predicting. The size …

News
Brilinta image

Mixed results for AstraZeneca in high-profile Brilinta study

March 17, 2015
Sales and Marketing American College of Cardiology, AstraZeneca, Brilinta, EMA, FDA, ticagrelor

Experts say AstraZeneca is at risk of ‘diminishing returns’ in the clinical advantages of its blood-thinning drug Brilinta, after it …

News
Lyrica image

Blow for Pfizer as Lyrica misses target

March 13, 2015
Sales and Marketing FDA, Lyrica, Pfizer, fibromyalgia, pain, pregablin

A late-stage study of Pfizer’s Lyrica has failed to demonstrate it has any significant pain reduction in patients with fibromyalgia. …

News
J&J image

J&J pleads guilty over children’s contaminated medicine

March 12, 2015
Manufacturing and Production, Sales and Marketing FDA, J&J, JJ, McNeil, OTC, Tylenol, consta, hamburg, recall

Johnson & Johnson’s consumer division McNeil has pleaded guilty and will pay fines of $25 million for wrongdoings regarding its …

News
Merck Serono image

Merck Serono bets on precision medicine

March 11, 2015
Sales and Marketing AstraZeneca, Diagnostics, FDA, Illumina, Merck Serono, opexa, personalised

Merck Serono is looking to expand further into personalised medicine as the company enters into an agreement with Illumina to …

News
Champix image

FDA gives new safety warning on Pfizer’s Champix

March 10, 2015
Manufacturing and Production, Sales and Marketing Champix, Cochrane, FDA, MHRA, Pfizer, varenicline

The FDA has warned that Pfizer’s stop smoking drug Champix is linked with seizures, aggressive behaviour and blackouts. In its …

News
Apple’s senior VP of operations Jeff Williams presented ResearchKit at the watch

Apple highlights ‘ResearchKit’ through watch launch

March 10, 2015
Medical Communications, Sales and Marketing Apple, FDA, digital, health, healthkit, researchkit, wearables

US tech giant Apple has finally launched its digital wearable device along with a ResearchKit platform that allows apps to …

News

FDA approves new anti-fungal treatment

March 9, 2015
Sales and Marketing Astellas, Basilea, FDA, US, cresemba, isavuconazonium sulfate, zygomycosis

The FDA has given the OK to Astellas and Basilea for their new treatment in adults with a rare but …

News
Novartis image

Novartis secures first US biosimilar product

March 6, 2015
Research and Development, Sales and Marketing Amgen, Cancer, FDA, Neupogen, Novartis, Sandoz, Zarxio, biosimilar, filgrastim-sndz

Novartis’ generic arm Sandoz has won the race to become the first company to market a biosimilar in the US …

News
Keytruda image

Merck and Eisai partner on cancer therapy trial

March 6, 2015
Research and Development, Sales and Marketing Bayer, Cancer, FDA, Halaven, Lenvima, Merck, Stivarga, keytruda, oncology, pd1

Merck and Eisai are teaming up for collaborative trials to test the effects of using combinations of each company’s oncology …

News

FDA launches drug shortages app

March 6, 2015
Medical Communications, Sales and Marketing Apple, FDA, app, drug, google, play, recall, shortages

The US Food and Drug Administration has launched its first smartphone app which provides valuable information about drug shortages. The …

News
Eisai image

Eisai launches Lenvima in US

March 2, 2015
Sales and Marketing FDA, Japan, Lenvima, US, dtc, thyroid

Japanese firm Eisai has launched its new thyroid cancer offering Lenvima in the US, making it the first country in …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026